Skip to Content

Cenobamate Approval Status

FDA Approved: No
Generic name: cenobamate
Company: SK Life Science, Inc.
Treatment for: Seizures

Cenobamate is a sodium channel blocker in development for the treatment of partial-onset seizures in adult patients.

Development Status and FDA Approval Process for cenobamate

DateArticle
Feb  4, 2019SK Life Science Announces FDA Acceptance of NDA Submission for Cenobamate, an Investigational Antiepileptic Drug

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide